Conceptual Considerations regarding Endpoints, Hypotheses, and Analyses for Incomplete Longitudinal Clinical Trial Data

Therapeutic Innovation & Regulatory Science

Volumn 43, Issue 4, 2009, Pages 449-458

  Mallinckrodt, Craig H ^a   Kenward, Michael G ^b  

^a ELI LILLY AND COMPANY   (United States)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

Clinical trials; Intention to treat; Longitudinal data; Missing data; Primary analysis; Sensitivity analysis

Indexed keywords

EID: 84996238075     PISSN: 21684790     EISSN: None     Source Type: Journal    
DOI: 10.1177/009286150904300410     Document Type: Article

References (47)

1. Little R., Rubin D. Statistical Analysis With Missing Data. New York: John Wiley; 1987.
2. Mallinckrodt CH, Lane PW, Schnell D, Peng Y, Mancuso JP. Recommendations for the primary analysis of continuous endpoints in longitudinal clinical trials. Drug Inf J. 2008; 42: 303–320.
3. Rubin DB. Inference and missing data. Biometrika. 1976; 63: 581–592.
4. Maldanado G, Greenland S. Estimating causal effects. Int J Epidemiol. 2002; 31: 422–429.
5. Frangakis CE, Rubin DB. Principal stratification in causal inference. Biometrics. 2002; 58: 21–29.
6. Molenberghs G, Thijs H, Jansen I, et al. Analyzing incomplete longitudinal clinical trial data. Biostatistics. 2004; 5: 445–464.
7. Mallinckrodt CH, Sanger TM, Dube S, et al. Assessing and interpreting treatment effects in longitudinal clinical trials with missing data. Biol Psychiatry. 2003; 53: 754–760.
8. Shao J, Zhong B. Last observation carry-forward and last observation analysis. Stat Med. 2003; 22: 2429–2441.
9. Mallinckrodt CH, Kaiser CJ, Watkin JG, Detke MJ, Molenberghs G, Carroll RJ. Type I error rates from likelihood-based repeated measures analyses of incomplete longitudinal data. Pharm Stat. 2004; 3: 171–186.
10. International Conference on Harmonization. Guideline E9, section 2.1.2. Available at: http://www.ich.org/cache/compo/276–254–1.html.
11. Verbeke G, Molenberghs G. Linear Mixed Models for Longitudinal Data. New York: Springer; 2000.
12. Liu G, Gould AL. Comparison of alternative strategies for analysis of longitudinal trials with dropouts. J Biopharm Stat. 2002; 12: 207–226.
13. Gadbury GL, Coffey CS, Allison DB. Modern statistical methods for handling missing repeated measurements in obesity trials: Beyond LOCF. Obes Rev. 2003; 4: 175–184.
14. Lane PW. Handling drop-out in longitudinal clinical trials: A comparison of the LOCF and MMRM approaches. Pharm Stat. (early view) 2007;DOI: 10.1002/pst.267.
15. Mallinckrodt CH, Clark WS, David SR. Accounting for dropout bias using mixed-effects models. J Biopharm Stat. 2001; 11: 9–21.
16. Mallinckrodt CH, Clark WS, David SR. Type I error rates from mixed effects model repeated measures versus fixed effects ANOVA with missing values imputed via last observation carried forward. Drug Inf J. 2001; 35: 1215–1225.
17. Mallinckrodt CH, Kaiser CJ, Watkin JG, Molenberghs G, Carroll RJ. The effect of correlation structure on treatment contrasts estimated from incomplete clinical trial data with likelihood-based repeated measures compared with last observation carried forward ANOVA. Clin Trials. 2004; 1: 477–489.
18. Gueorguieva R, Krystal JH. Move over ANOVA: Progress in analyzing repeated measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiatry. 2004; 61: 310–317.
19. Shen S, Beunckens C, Mallinckrodt C, Molenberghs G. A local influence sensitivity analysis for incomplete longitudinal depression data. J Biopharm Stat. 2006; 16: 365–384.
20. Collins LM, Schafer JL, Kam CM. A comparison of inclusive and restrictive strategies in modern missing data procedures. Psychol Methods. 2001; 6: 330–351.
21. Rubin DB. Multiple Imputation for Nonresponse in Surveys. Chichester, UK: Wiley; 1987.
22. Carpenter J, Kenward MG. Missing data in randomised controlled trials: a practical guide. 2007. Available at: http://www.pcpoh.bham.ac.uk/publichealth/nccrm/PDFs_and_documents/Publications/Final_Report_RM04JH17_mk.pdf.
23. Lipkovich I, Duan Y, Ahmed S. Multiple imputation compared with restricted pseudo-likelihood and generalized estimating equations for analysis of binary repeated measures in clinical studies. Pharm Stat. 2005; 4: 267–285.
24. Molenberghs G, Kenward MG, Lesaffre E. The analysis of longitudinal ordinal data with non-random dropout. Biometrika. 1997; 84: 33–44.
25. Laird NM, Discussion to Diggle PJ, Kenward MG. Informative dropout in longitudinal data analysis. Appl Stat. 1994; 43: 84.
26. Little RJA. Modeling the drop-out mechanism in repeated measures studies. J Am Stat Assoc. 1995; 90: 1112–1121.
27. Rubin DB, Discussion to Diggle PJ Kenward MG. Informative dropout in longitudinal data analysis. Appl Stat. 1994; 43: 80–82.
28. Copas JB, Li HG. Inference for non-random samples (with discussion). J R Stat Soc B. 1997; 59: 55–96.
29. Draper D. Assessment and propagation of model uncertainty (with discussion). J R Stat Soc B. 1995; 57: 45–97.
30. Kenward MG. Selection models for repeated measurements with non-random dropout: An illustration of sensitivity. Stat Med. 1998; 17: 2723–2732.
31. Little R, Rubin D. Statistical Analysis With Missing Data. New York: John Wiley; 1987.
32. Rubin DB. Inference and missing data. Biometrika. 1976; 63: 581–592.
33. Diggle PJ, Kenward MG. Informative dropout in longitudinal data analysis (with discussion). Appl Stat. 1994; 43: 49–93.
34. Rotnitzky A, Robins JM, Scharfstein DO. Semiparametric regression for repeated outcomes with nonignorable nonresponse. J Am Stat Assoc. 1998; 93: 1321–1339.
35. Little RJA. Pattern-mixture models for multivariate incomplete data. J Am Stat Assoc. 1993; 88: 125–134.
36. Little RJA. A class of pattern-mixture models for normal incomplete data. Biometrika. 1994; 81: 471–483.
37. Wu MC, Carroll RJ. Estimation and comparison of changes in the presence of informative right censoring by modeling the censoring process. Biometrics. 1988; 44: 175–188.
38. Ten Have TR, Kunselman AR, Pulkstenis EP, Landis JR. Mixed effects logistic regression models for longitudinal binary response data with informative drop-out. Biometrics. 1998; 54: 367–383.
39. Wu MC, Bailey KR. Estimation and comparison of changes in the presence of informative right censoring: Conditional linear model. Biometrics. 1989; 45: 939–955.
40. Mori M, Woodworth GG, Woolson RF. Application of empirical Bayes inference to estimation of rate of change in the presence of informative right censoring. Stat Med. 1992; 11: 621–631.
41. Follmann D, Wu M. An approximate generalized linear model with random effects for informative missing data. Biometrics. 1995; 51: 151–168.
42. Little RJA, Yau L. Intent-to-treat analysis for longitudinal studies with dropout-outs. Biometrics. 1996; 52: 1324–1333.
43. Molenberghs G, Kenward MG. Missing Data in Clinical Studies. Chichester: John Wiley; 2007.
44. Rubin DB, Stern HS, Vehovar V. Handling “don't know” survey responses: The case of the Slovenian plebiscite. J Am Stat Assoc. 1995; 90: 822–828.
45. Lieberman JA, Greenhouse J, Hamer RM, et al. Comparing the effects of antidepressants: Consensus guidelines for evaluating quantitative reviews of antidepressant efficacy. Neuropsychopharmacology. 2005; 30: 445–460.
46. Mallinckrodt CH, Watkin JG, Molenberghs G, Carroll RJ. Choice of the primary analysis in longitudinal clinical trials. Pharm Stat. 2004; 3: 161–169.
47. Leon AC, Mallinckrodt CH, Chuang-Stein C, Archibald DG, Archer GE, Chartier K. Attrition in randomized controlled clinical trials: Methodological issues in psychopharmacology. Biol Psychiatry. 2006; 59: 1001–1005.